GatePass Capital’s Neuronetics STIM Stock Holding History

GatePass Capital’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,172	Closed	-$165K	–	153
2025 Q2	$165K	Hold	47,172	–	–	0.11%	119
2025 Q1	$174K	Buy	+47,172	New	+$172K	0.13%	108

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GatePass Capital's STIM Position: Q3 2025 in Review

GatePass Capital sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 47,172 shares — an estimated $165K sold.

GatePass Capital first reported a position in STIM in Q1 2025 and held it in 2 quarters. The position peaked at $174K in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

GatePass Capital reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
GatePass Capital sold 47,172 Neuronetics shares in Q3 2025, an estimated $165K.
GatePass Capital first reported a position in Neuronetics in Q1 2025 and held it in 2 quarters.
GatePass Capital's Neuronetics position peaked at $174K in Q1 2025.
99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on GatePass Capital's 13F filing for Q3 2025, filed 29 Oct 2025.